Search research articles
Contact Us
Filters
Showing results (401-410 of 458) with videos related to
Page
of 46
Sort By:
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1987
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A
J Nussberger, M de Gasparo, L Juillerat, et al.
Journal of Hypertension
|
January 1, 1990
Prevention of renal hypertension in the rat by neuropeptide Y
B Waeber, D Evéquoz, J F Aubert, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1986
Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects
J P Bussien, T F d'Amore, L Perret, et al.
International Journal of Clinical Practice
|
August 10, 2007
The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
H A J Struijker-Boudier, E Ambrosioni, H Holzgreve, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
January 1, 1989
[Effects of clonidine on tourniquet-induced systemic arterial hypertension in general anesthesia]
P Y Erard, J P Gardaz, J Nussberger, et al.
American Journal of Hypertension
|
September 1, 1989
Effect of cold pressor test on the internal diameter of the radial artery
F Perret, V Mooser, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 1, 1995
Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats
J A Haefliger, G Bergonzelli, G Waeber, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1988
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels
J F Aubert, M Burnier, B Waeber, et al.
British Journal of Clinical Pharmacology
|
January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension
H R Brunner, H Gavras, B Waeber, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model
R J Francis, A N Brown, L Kler, et al.
Page
of 46
Search research articles
Search
Showing results (401-410 of 458) with videos related to
Sort By:
Page
of 46
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1987
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A
J Nussberger, M de Gasparo, L Juillerat, et al.
Journal of Hypertension
|
January 1, 1990
Prevention of renal hypertension in the rat by neuropeptide Y
B Waeber, D Evéquoz, J F Aubert, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1986
Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects
J P Bussien, T F d'Amore, L Perret, et al.
International Journal of Clinical Practice
|
August 10, 2007
The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
H A J Struijker-Boudier, E Ambrosioni, H Holzgreve, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
January 1, 1989
[Effects of clonidine on tourniquet-induced systemic arterial hypertension in general anesthesia]
P Y Erard, J P Gardaz, J Nussberger, et al.
American Journal of Hypertension
|
September 1, 1989
Effect of cold pressor test on the internal diameter of the radial artery
F Perret, V Mooser, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 1, 1995
Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats
J A Haefliger, G Bergonzelli, G Waeber, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1988
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels
J F Aubert, M Burnier, B Waeber, et al.
British Journal of Clinical Pharmacology
|
January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension
H R Brunner, H Gavras, B Waeber, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model
R J Francis, A N Brown, L Kler, et al.
Page
of 46